PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Insmed Incorporated (INSM)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US4576693075

CUSIP

457669307

Sector

Healthcare

IPO Date

Jun 1, 2000

Highlights

Market Cap

$12.35B

EPS (TTM)

-$5.55

Total Revenue (TTM)

$259.27M

Gross Profit (TTM)

$197.15M

EBITDA (TTM)

-$604.97M

Year Range

$21.92 - $80.53

Target Price

$88.25

Short %

7.37%

Short Ratio

7.57

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
INSM vs. SRPT INSM vs. LLY INSM vs. NVDA
Popular comparisons:
INSM vs. SRPT INSM vs. LLY INSM vs. NVDA

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Insmed Incorporated, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-0.19%
6.74%
INSM (Insmed Incorporated)
Benchmark (^GSPC)

Returns By Period

Insmed Incorporated had a return of 1.19% year-to-date (YTD) and 139.82% in the last 12 months. Over the past 10 years, Insmed Incorporated had an annualized return of 16.43%, outperforming the S&P 500 benchmark which had an annualized return of 11.51%.


INSM

YTD

1.19%

1M

-7.30%

6M

-0.20%

1Y

139.82%

5Y*

24.15%

10Y*

16.43%

^GSPC (Benchmark)

YTD

1.03%

1M

-2.37%

6M

6.74%

1Y

26.74%

5Y*

12.96%

10Y*

11.51%

*Annualized

Monthly Returns

The table below presents the monthly returns of INSM, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-10.29%-0.29%-2.13%-8.88%122.69%21.71%8.58%5.11%-4.54%-7.84%11.71%-8.14%122.78%
20237.76%-5.34%-16.34%14.37%-2.41%10.88%4.69%-0.91%15.35%-0.75%-0.16%23.86%55.11%
2022-16.74%5.38%-1.67%-6.51%-14.34%4.78%12.17%11.30%-12.51%-19.59%6.76%8.06%-26.65%
202112.92%-4.84%-4.78%-0.97%-27.07%15.69%-13.56%13.98%-1.78%9.48%-8.72%-1.02%-18.17%
2020-13.99%21.23%-35.62%43.48%5.61%13.38%-5.16%7.92%14.01%2.49%18.43%-14.66%39.41%
201985.29%21.97%-1.96%4.71%-20.47%5.74%-14.26%-25.10%7.30%5.39%23.99%3.60%82.01%
2018-18.41%-4.83%-6.98%8.04%14.51%-15.11%5.16%-19.86%1.46%-27.79%22.67%-26.74%-57.92%
201711.64%7.85%9.92%5.37%-16.42%11.28%-5.77%-23.19%151.29%-13.46%15.48%-0.03%135.68%
2016-27.27%-7.35%3.60%-4.10%-2.88%-16.44%16.13%13.10%12.12%-10.61%5.16%-3.08%-27.11%
2015-0.06%19.92%12.19%-3.65%9.48%11.30%10.97%-9.82%-24.02%6.84%-17.79%11.28%17.32%
201420.12%-2.01%-4.85%-26.79%-5.74%52.05%-14.46%-18.49%-6.32%8.74%-0.56%9.64%-9.00%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 92, INSM is among the top 8% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of INSM is 9292
Overall Rank
The Sharpe Ratio Rank of INSM is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of INSM is 9999
Sortino Ratio Rank
The Omega Ratio Rank of INSM is 9797
Omega Ratio Rank
The Calmar Ratio Rank of INSM is 8787
Calmar Ratio Rank
The Martin Ratio Rank of INSM is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Insmed Incorporated (INSM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for INSM, currently valued at 1.14, compared to the broader market-4.00-2.000.002.001.142.08
The chart of Sortino ratio for INSM, currently valued at 5.23, compared to the broader market-4.00-2.000.002.004.005.232.78
The chart of Omega ratio for INSM, currently valued at 1.61, compared to the broader market0.501.001.502.001.611.38
The chart of Calmar ratio for INSM, currently valued at 1.62, compared to the broader market0.002.004.006.001.623.10
The chart of Martin ratio for INSM, currently valued at 16.29, compared to the broader market0.005.0010.0015.0020.0025.0016.2913.27
INSM
^GSPC

The current Insmed Incorporated Sharpe ratio is 1.14. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Insmed Incorporated with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.50AugustSeptemberOctoberNovemberDecember2025
1.14
2.08
INSM (Insmed Incorporated)
Benchmark (^GSPC)

Dividends

Dividend History


Insmed Incorporated doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-64.17%
-2.43%
INSM (Insmed Incorporated)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Insmed Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Insmed Incorporated was 98.65%, occurring on Nov 25, 2011. The portfolio has not yet recovered.

The current Insmed Incorporated drawdown is 64.17%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.65%Aug 31, 20002827Nov 25, 2011
-35.29%Jun 6, 200024Jul 10, 200017Aug 2, 200041
-28.67%Aug 4, 200010Aug 17, 20007Aug 28, 200017
-3.03%Jun 2, 20001Jun 2, 20001Jun 5, 20002

Volatility

Volatility Chart

The current Insmed Incorporated volatility is 9.42%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
9.42%
4.36%
INSM (Insmed Incorporated)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Insmed Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Insmed Incorporated.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab